View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
VA RIN: 2900-AQ31 Publication ID: Spring 2018 
Title: ●Elimination of Copayment for Opioid Antagonists and Education on Use of Opioid Antagonists 
Abstract:

The Department of Veterans Affairs (VA) is amending its medical regulations that govern copayments to conform with recent statutory requirements. VA is eliminating the copayment requirement for veterans at high risk of suicide who are prescribed opioid antagonists. VA is also clarifying that no copayment will be required for the provision of education on the use of opioid antagonists. This final rule is an essential part of VA’s attempts to help veterans at risk of suicide.

 
Agency: Department of Veterans Affairs(VA)  Priority: Substantive, Nonsignificant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
EO 14192 Designation: Other 
CFR Citation: 38 CFR 17.108    38 CFR 17.110   
Legal Authority: Pub. L. 114-198, sec. 915    Pub. L. 114-223, sec. 243   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Interim Final Rule  10/00/2018 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Sandra Mize
Program Analyst (CBO FO)
Department of Veterans Affairs
3773 Cherry Creek North Drive,
Denver, CO 80209
Phone:303 331-7545
Email: sandra.mize@va.gov